721876-16-0 Usage
Uses
Used in Pharmaceutical Synthesis:
4-Methylpiperazine-2-carboxylic acid is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to form stable derivatives with potential therapeutic properties.
Used in Drug Delivery Systems:
4-Methylpiperazine-2-carboxylic acid is used as a component in drug delivery systems to enhance the bioavailability and targeted delivery of therapeutic agents, improving their efficacy and reducing side effects.
Used in Anti-tumor Applications:
4-Methylpiperazine-2-carboxylic acid is used as a potential anti-tumor agent for its ability to inhibit the growth and proliferation of cancer cells, making it a promising candidate for the development of novel cancer therapies.
Used in Anti-inflammatory Applications:
4-Methylpiperazine-2-carboxylic acid is used as a potential anti-inflammatory agent for its ability to modulate inflammatory responses and alleviate symptoms associated with various inflammatory conditions.
Used in Bioactive Compound Synthesis:
4-Methylpiperazine-2-carboxylic acid is used as a building block in the synthesis of bioactive compounds, contributing to the development of new drugs with diverse therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 721876-16-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,8,7 and 6 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 721876-16:
(8*7)+(7*2)+(6*1)+(5*8)+(4*7)+(3*6)+(2*1)+(1*6)=170
170 % 10 = 0
So 721876-16-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H12N2O2/c1-8-3-2-7-5(4-8)6(9)10/h5,7H,2-4H2,1H3,(H,9,10)
721876-16-0Relevant articles and documents
DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS
-
Paragraph 0493 - 0495; 1219 - 1221, (2015/06/10)
Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically, provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.
DIHYDROPYRIMIDINE COMPOUNDS AND THEIR APPLICATION IN PHARMACEUTICALS
-
Paragraph 00225; 00477, (2014/03/25)
Provided herein are dihydropyrimidine compounds and their pharmaceutical applications, especially for use in treating and preventing HBV diseases. Specifically,provided herein are compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof, wherein the variables of the formulas are as defined in the specification. Also provided herein is the use of the compounds having Formula (I) or (Ia), or an enantiomer, a diastereoisomer, a tautomer, a hydrate, a solvate, or a pharmaceutically acceptable salt thereof for treating and preventing HBV diseases.
